These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 3865485)

  • 1. Experimental work with anabolics in autoimmunity models.
    Schuurs AH; Verheul HA; Schot LP
    Acta Endocrinol Suppl (Copenh); 1985; 271():97-108. PubMed ID: 3865485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic effects of nandrolone decanoate, tibolone, lynestrenol and ethylestrenol on Sjögren's syndrome-like disorder in NZB/W mice.
    Verheul HA; Schot LP; Schuurs HW
    Clin Exp Immunol; 1986 May; 64(2):243-8. PubMed ID: 3742875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of nandrolone, testosterone and their decanoate esters on murine lupus.
    Verheul HA; Stimson WH; den Hollander FC; Schuurs AH
    Clin Exp Immunol; 1981 Apr; 44(1):11-7. PubMed ID: 6973425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of nandrolone decanoate or testosterone decanoate on murine lupus: further evidence for a dissociation of autoimmunosuppressive and endocrine effects.
    Verheul HA; Deckers GH; Schuurs AH
    Immunopharmacology; 1986 Apr; 11(2):93-9. PubMed ID: 3710768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of nandrolone decanoate on Sjögren's syndrome like disorders in NZB/NZW mice.
    Schot LP; Verheul HA; Schuurs AH
    Clin Exp Immunol; 1984 Sep; 57(3):571-4. PubMed ID: 6467680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of nandrolone decanoate in NZB/W mice treated concomitantly with maintenance doses of dexamethasone sodium phosphate.
    Verheul HA; Deckers GH; Schuurs AH
    Int J Immunopharmacol; 1985; 7(2):249-54. PubMed ID: 4008140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of tibolone, lynestrenol, ethylestrenol, and desogestrel on autoimmune disorders in NZB/W mice.
    Verheul HA; Schot LP; Deckers GH; Schuurs AH
    Clin Immunol Immunopathol; 1986 Feb; 38(2):198-208. PubMed ID: 2934198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progress toward production of immunologic tolerance with no or minimal toxic immunosuppression for prevention of immunodeficiency and autoimmune diseases.
    Good RA
    World J Surg; 2000 Jul; 24(7):797-810. PubMed ID: 10833246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ciclosporin treatment in experimental autoimmune myasthenia gravis.
    Gunn HC; Hiestand PC; Hanglow AC
    Monogr Allergy; 1988; 25():96-107. PubMed ID: 3262820
    [No Abstract]   [Full Text] [Related]  

  • 10. Differences in the occurrence of hypertension among (NZB X NZW)F1, MRL-lpr, and BXSB mice with lupus nephritis.
    Rudofsky UH; Dilwith RL; Roths JB; Lawrence DA; Kelley VE; Magro AM
    Am J Pathol; 1984 Jul; 116(1):107-14. PubMed ID: 6377906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Murine models of Sjögren's syndrome. Evolution of the lacrimal gland inflammatory lesions.
    Jabs DA; Enger C; Prendergast RA
    Invest Ophthalmol Vis Sci; 1991 Feb; 32(2):371-80. PubMed ID: 1993589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Testosterone-induced suppression of autoimmune disease in lacrimal tissue of a mouse model (NZB/NZW F1) of Sjögren's syndrome.
    Vendramini AC; Soo C; Sullivan DA
    Invest Ophthalmol Vis Sci; 1991 Oct; 32(11):3002-6. PubMed ID: 1917404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sjögren's syndrome in MRL/l and MRL/n mice.
    Hoffman RW; Alspaugh MA; Waggie KS; Durham JB; Walker SE
    Arthritis Rheum; 1984 Feb; 27(2):157-65. PubMed ID: 6421291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of gender on exocrine gland inflammation in mouse models of Sjögren's syndrome.
    Toda I; Sullivan BD; Rocha EM; Da Silveira LA; Wickham LA; Sullivan DA
    Exp Eye Res; 1999 Oct; 69(4):355-66. PubMed ID: 10504269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of thymectomy or androgen administration upon the autoimmune disease of MRL/Mp-lpr/lpr mice.
    Steinberg AD; Roths JB; Murphy ED; Steinberg RT; Raveche ES
    J Immunol; 1980 Aug; 125(2):871-3. PubMed ID: 7391583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polyclonal B cell activation arises from different mechanisms in lupus-prone (NZB x NZW)F1 and MRL/MpJ-lpr/lpr mice.
    Merino R; Iwamoto M; Fossati L; Izui S
    J Immunol; 1993 Dec; 151(11):6509-16. PubMed ID: 7902378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spontaneous autoimmune disease in (NZB x NZW)F1 mice is ameliorated by treatment with methimazole.
    Mozes E; Zinger H; Kohn LD; Singer DS
    J Clin Immunol; 1998 Mar; 18(2):106-13. PubMed ID: 9533654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional and quantitative changes of immune cells of ageing NZB mice treated with nandrolone decanoate. I. Effect on survival and autoantibody development.
    Bruley-Rosset M; Dardenne M; Schuurs A
    Clin Exp Immunol; 1985 Dec; 62(3):630-8. PubMed ID: 3878753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of sex, gonadectomy and several steroids on the development of insulin-dependent diabetes mellitus in the BB rat.
    Verheul HA; Schot LP; Schuurs AH
    Clin Exp Immunol; 1986 Mar; 63(3):656-62. PubMed ID: 3708906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Murine models of systemic lupus erythematosus: B and T cell responses to spliceosomal ribonucleoproteins in MRL/Fas(lpr) and (NZB x NZW)F(1) lupus mice.
    Monneaux F; Dumortier H; Steiner G; Briand JP; Muller S
    Int Immunol; 2001 Sep; 13(9):1155-63. PubMed ID: 11526096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.